ABB is a pharmaceutical company working in the sector of Dermatology they start their business in Jan 2012 with one product called (x) that is antihistaminic product.

A- Using the following data kindly you are requested to make marketing plan for the (x) Product for 2012

The total market divided between A, B, C, D companies which company A take 30% from the market with its product (G) with price 26 LE, company B take 15% from the market with its product (H) with price 31 LE while Company C take 25% from the market with its product (K) with price 22 LE and company D take 30% from the market with its product (L) with price 8 LE.

Company ABB product has new technique which called Nano granules so patient can use this drug one daily not twice as other products plus there is no sedation with (x) product.

B- ABB Company hires 250 employee 200 in sales, 10 in marketing, 6 accountants, and 5 in HR, 4 Admin and 25 employees for distribution.

So you are kindly requested to make the following:-

- Hierarchy for the organization.

- Job analysis for each job.

- Salary box for each job.

C- Kindly give detailing for job steps and procedures and parameters for each step to ensure quality management.

D- In the beginning of 2013 there was an opportunity for tender in ministry of health with profit 10,000,000 LE so kindly give details on how you will manage this project.

E- Using the following data kindly you are requested to make Balance sheet, Current ratio and Quick ratio for the company

Accounts and Notes Receivable 483.5

Notes Receivable due after one year 67

Intangible Assets 827.5

Account payable 650.6

Taxes Payable 201

Long term debt 4834.1

Retained Earnings 8144.1

Other long-term liabilities 1491

Contributed Capital 787.8

Total Non Current Liabilities 6325.1

Property and equipment?s Net 14961.4

Other noncurrent Assets 608.5

Notes payable (Short Term) 1293.8

Long term investment 634.8

Accrued Liabilities 503.5

Current Maturities of long term debt 335.6

Cash and Equivalents 341.4

Inventories 70.5

Prepaid expenses and other current Assets 246.9

Total Market Antihistaminic 2009 13,854,517,000 153,936,000 2010 16,073,198,000 170,211,000 2011 18,133,485,000 190,802,000